Treatment outlines for the management of primary leiomyosarcoma of the inferior vena cava - 10/06/22
Doi : 10.1016/j.jdmv.2022.04.005
Ottavia Borghese a, b, ⁎ 
, Angelo Pisani a, c, Julien Dubrez d, Isabelle Di Centa b
, Angelo Pisani a, c, Julien Dubrez d, Isabelle Di Centa b a Sapienza University, Rome, Italy
b Department of Vascular and Endovascular Surgery, Foch Hospital, Suresnes, France
c Department of Cardiovascular Surgery, Azienda Ospedaliera Santa Maria della Misericordia, Perugia, Italy
d Department of Gastrointestinal Surgery, Foch Hospital, Suresnes, France
⁎Corresponding author at: Sapienza University, Viale del Policlinico, 00100 Rome, Italy.Sapienza UniversityViale del PoliclinicoRome00100Italy
Summary |
Primary venous Leiomyosarcoma (LMSs) are extremely rare tumours with poor survival rates. Surgery is currently the only potentially curative therapy in non-metastatic disease, but it consists in challenging interventions. The authors report the experience of one single centre in the treatment of LMS and a literature overview focusing on the diverse methods of vessels repair. Outcomes achieved are also outlined.
Le texte complet de cet article est disponible en PDF.Keywords : Inferior vena cava, Leiomyosarcoma, Retroperitoneal sarcoma, Surgical resection, Vascular reconstruction
Plan
© 2022
Elsevier Masson SAS. Tous droits réservés.
Vol 47 - N° 2
P. 65-70 - avril 2022 Retour au numéro
Article précédent
- Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study
- C. Frere, B. Crichi, J.A. Rueda-Camino, F. Cajfinger, N. Spiess, N. Janus, C. Le Maignan, Z. Marjanovic, D. Farge
- Frequency and factors associated with arterial remodeling in persons living with human immunodeficiency virus in Parakou in 2019
- H.L. Codjo, C.A. Attinsounon, R. Mele, S.H.M. Dohou, K.D. Rouga, H.N. Amegan, C.O.A. Biaou, V. Sylvestri, R. Caronna, M. Houenassi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?